Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-149,176
Closed -$127K 1022
2023
Q1
$127K Buy
149,176
+465
+0.3% +$507 ﹤0.01% 993
2022
Q4
$193K Buy
148,711
+30,481
+26% +$47.5K ﹤0.01% 1003
2022
Q3
$210K Sell
118,230
-9,700
-8% -$24.1K ﹤0.01% 1000
2022
Q2
$290K Buy
+127,930
New +$306K ﹤0.01% 842

Other funds holding OCGN

ALPS Advisors's OCGN Position: Q2 2023 in Review

ALPS Advisors sold out of Ocugen (OCGN) in Q2 2023, closing a stake of 149,176 shares — an estimated $127K sold.

ALPS Advisors first reported a position in OCGN in Q2 2022 and held it in 4 quarters. The position peaked at $290K in Q2 2022. 96 funds tracked by Wall St. Rank hold OCGN as of Q2 2023.

  • ALPS Advisors reported no remaining Ocugen position as of Q2 2023 after selling out during the quarter.
  • ALPS Advisors sold 149,176 Ocugen shares in Q2 2023, an estimated $127K.
  • ALPS Advisors first reported a position in Ocugen in Q2 2022 and held it in 4 quarters.
  • ALPS Advisors's Ocugen position peaked at $290K in Q2 2022.
  • 96 funds tracked by Wall St. Rank held Ocugen as of Q2 2023.

Based on ALPS Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.